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Conﬂicts	  of	  Interest	  
•  I	  do	  not	  receive	  salary	  compensa=on	  from	  
anyone	  other	  than	  my	  current	  employer,	  CSHL	  .	  	  
	  
•  Any	  revenue	  that	  I	  earn	  from	  providing	  medical	  
care	  in	  Utah	  is	  donated	  to	  UFBR	  for	  gene=cs	  
research.	  
“Happy	  families	  are	  all	  alike;	  every	  
unhappy	  family	  is	  unhappy	  in	  its	  
own	  way.”	  
	  Leo	  Tolstoy,	  Anna	  Karenina,	  Chapter	  
1,	  ﬁrst	  line	  
Russian	  mys6c	  &	  novelist	  (1828	  -­‐	  
1910)	  	  
*First	  heard	  quote	  in	  human	  gene=cs	  from	  Mary-­‐Claire	  King	  
“We	  don’t	  have	  to	  look	  for	  a	  model	  
organism	  anymore,	  because	  we	  are	  
the	  model	  organisms.”	  
	  
–	  Sydney	  Brenner,	  Nobel	  Laureate,	  
quote	  in	  2008	  
Hypothesis: Every	  human	  is	  a	  
unique	  gene=c	  organism.	  
Therefore,	  we	  can	  ﬁnd	  previously	  
unreported	  idiopathic	  disorders	  in	  
humans	  and	  iden=fy	  their	  gene=c	  
basis,	  thus	  revealing	  substan=al	  
new	  biology	  relevant	  to	  medicine.	  	  
	  

•  Seguin	  E.	  1866,	  Idiocy	  and	  its	  treatment	  by	  the	  
physiological	  method.	  
•  -­‐	  	  “our	  incomplete	  studies	  do	  not	  permit	  
actual	  classiﬁca=on;	  but	  it	  is	  be]er	  to	  leave	  
things	  by	  themselves	  rather	  than	  to	  force	  
them	  into	  classes	  which	  have	  their	  founda=on	  
only	  on	  paper”.	  
OBSERVATIONS ON AN ETHNIC CLASSIFICATION OF IDIOTS *
J. LANGDON H. DOWN M.D., London
THOSE who have given any attention to congenital mental lesions, must have
been frequently puzzled how to arrange, in any satisfactory way, the different
classes of this defect which may have come under their observation. Nor
will the difficulty be lessened by an appeal to what has been written on the
subject. The systems of classification are generally so vague and artificial,
that, not only do they assist but feebly, in any mental arrangement of the
phenomena which are presented, but they completely fail in exerting anypractical influence on the subject.
The medical practitioner who may be consulted in any given case, has,
perhaps in a very early condition of the child's life, to give an opinion on
points of vital importance as to the present condition and probable future of
the little one. Moreover, he may be pressed as to the question, whether the
supposed defect dates from any cause subsequent to the birth or not. Has
the nurse dosed the child with opium? Has the little one met with any
accident? Has the instrumental interference which maternal safety de-
manded, been the cause of what seems to the anxious parents, a vacant future?
Can it be that when away from the family attendant the calomel powders
were judiciously prescribed? Can, in fact, the strange anomalies which the
child presents, be attributed to the numerous causes which maternal solici-
tude conjures to the imagination, in order to account for a condition, for
which any cause is sought, rather than hereditary taint or parental influence.
Will the systems of classification, either all together, or any one of them,
assist the medical adviser in the opinion he is to present, or the suggestions
which he is to tender to the anxious parent? I think that they will entirely
fail him in the matter, and that he will have in many cases to make a guarded
diagnosis and prognosis, so guarded, in fact, as to be almost valueless, or to
venture an authoritative assertion which the future may perhaps confirm.
I have for sometime had my attention directed to the possibility of
making a classification of the feeble minded by arranging them around
various ethnic standards—in other words, framing a natural system to
supplement the information to be derived by an inquiry into the history of
the case.
I have been able to find among the large number of idiots and imbeciles
which come under my observation, both at Earlswood and the out-patient
department of the Hospital, that a considerable portion can be fairly re-
ferred to one of the great divisions of the human family other than the class
from which they have sprung. Of course, there are numerous representatives
of the great Caucasian family. Several well-marked examples of the Ethi-
opian variety have come under my notice, presenting the characteristic
malar bones, the prominent eyes, the puffy lips, and retreating chin. The
* This paper from the London Hospital Clinical Report 3, 259-262 (i866) is republishedon account of its historical interest (see page 698). The editors are indebted to Dr J. H.
Edwards, The Medical School, University of Birmingham who proposed republication and
provided the copy.
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The life expectancy, however, is far below the average, and the tendency is
to the tuberculosis, which I believe to be the hereditary origin of the
degeneracy.Apart from the practical bearing of this attempt at an ethnic classification,
considerable philosophical interest attaches to it. The tendency in the
present day is to reject the opinion that the various races are merely varieties
of the human family having a common origin, and to insist that climatic,
or other influences, are insufficient to account for the different types of man.
Here, however, we have examples of retrogression, or at all events, of de-
parture from one type and the assumption of the characteristics of another.
If these great racial divisions are fixed and definite, how comes it that disease
is able to break down the barrier, and to simulate so closely the features os
the members of another division. I cannot but think that the observations
which I have recorded are indications that the differences in the races are not
specific but variable.
These examples of the result of degeneracy among mankind, appear to me
to furnish some arguments in favour of the unity of the human species.
London Hospital Cli ical Lecture Report. 3, 259-262, i866.
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“Those	  who	  hav 	  given	  any	  a] n= n	  to	  congenital	  mental	  
lesions,	  must	  have	  been	  frequently	  puzzled	  how	  to	  arrange,	  in	  
any	  sa=sfactory	  way,	  the	  diﬀerent	  classes	  of	  this	  defect	  which	  
may	   ave	  come	  under	  their	  observa=on.	  Nor	  will	  the	  diﬃculty	  be	  
lessened	  by	  an	  appeal	  to	  what	  has	  been	  wri]en	  on	  the	  subject.	  
The	  systems	  of	  classiﬁca=on	  are	  generally	  so	  vague	  and	  ar=ﬁcial,	  
that,	  not	  only	  do	  they	  assist	  but	  feebly,	  in	  any	  mental	  
arra gement	  of	  the	  phenomena	  represented,	  but	  they	  
completely	  fail	  in	  exer=ng	  a y	  prac=cal	  inﬂuenc 	  on	  the	  subject.”	  
	  
	  
The	  Big	  Picture	  
•  Over	  the	  course	  of	  my	  en=re	  career,	  I	  want	  to	  
help	  understand	  the	  pathophysiology	  of	  severe	  
neuropsychiatric	  disorders,	  including	  such	  things	  
as	  developmental	  delay,	  mental	  retarda=on,	  
au=sm,	  psycho=c	  disorders	  (schizophrenia,	  
bipolar,	  schizoaﬀec=ve),	  Toure]e	  Syndrome	  and	  
obsessive	  compulsive	  disorder.	  
•  I	  expect	  this	  to	  uncover	  new	  biology	  along	  the	  
way.	  
Most	  recent	  analysis	  in	  Europe	  showed	  that	  brain	  disorders	  cost	  almost	  US
$1	  trillion	  year	  per	  year,	  more	  than	  cancer,	  cardiovascular	  disease	  and	  
diabetes	  combined.	  
	  







Other-­‐	  brain	  tumor,	  child/adolescent	  developmental	  disorders	  (au$sm,	  
ADHD,	  $cs,	  etc…),	  ea=ng	  disorders,	  epilepsy,	  mental	  retarda$on,	  mul=ple	  
sclerosis,	  neuromuscular	  disorders,	  Parkinson’s,	  personality	  disorders,	  sleep	  
disorders,	  somatoform	  disorder,	  stroke	  and	  trauma=c	  brain	  injury.	  
	  
*	  Cost	  of	  disorders	  of	  the	  brain	  in	  Europe	  2010.	  
Gustavsson	  A,	  et	  al.	  
Eur	  Neuropsychopharmacol.	  2011	  Oct;21(10):718-­‐779.	  Epub	  2011	  Sep	  15.	  
	  
	  
The	  toll	  with	  Brain	  Disorders	  is	  tremendous.	  

I	  moved	  to	  Utah	  in	  July	  2009	  to	  ﬁnd	  new	  
human	  gene$c	  syndromes,	  thus	  revealing	  new	  
biology.	  
	  
  July	  2009-­‐December	  2009:	  ASended	  weekly	  
gene$cs	  case	  conference	  in	  which	  10-­‐30	  gene$c	  
cases	  are	  presented	  weekly,	  led	  by	  Dr.	  Alan	  Rope	  
and	  aSended	  by	  Drs.	  John	  Carey	  and	  John	  Opitz.	  
	  
  There	  are	  indeed	  MANY	  idiopathic	  disorders	  not	  
described	  in	  the	  literature,	  many	  of	  which	  have	  
neuropsychiatric	  manifesta$ons.	  I	  thought	  about	  
hundreds	  of	  such	  cases,	  looking	  for	  ideal	  ﬁrst	  
families	  to	  sequence.	  
Beyond	  our	  Kuhnian	  inheritance	  
A	  recent	  lecture	  by	  Prof	  Greg	  Radick	  ques=ons	  our	  scien=ﬁc	  inheritance,	  
through	  textbook	  histories	  of	  gene=cs	  and	  Thomas	  Kuhn's	  legacy	  
h]p://www.guardian.co.uk/science/the-­‐h-­‐word/2012/aug/28/thomas-­‐
kuhn	  
Walter	  Frank	  Raphael	  Weldon	  
Vs.	  	  
William	  Bateson	  
Forthcoming	  by	  Greg	  Radick.	  Scholarly	  edi=on	  of	  W.	  F.	  R.	  Weldon's	  Theory	  of	  
Inheritance	  (1904-­‐1905),	  coedited	  with	  Annie	  Jamieson.	  
“The	  fundamental	  mistake	  which	  vi=ates	  all	  work	  based	  
upon	  Mendel’s	  method	  is	  the	  neglect	  of	  ancestry,	  and	  the	  
a]empt	  to	  regard	  the	  whole	  eﬀect	  upon	  oﬀspring,	  
produced	  by	  a	  par=cular	  parent,	  as	  due	  to	  the	  existence	  
in	  the	  parent	  of	  par=cular	  structural	  characters;	  while	  the	  
contradictory	  results	  obtained	  by	  those	  who	  have	  
observed	  the	  oﬀspring	  of	  parents	  apparently	  iden=cal	  in	  
certain	  characters	  show	  clearly	  enough	  that	  not	  only	  the	  
parents	  themselves,	  but	  their	  race,	  that	  is	  their	  ancestry,	  
must	  be	  taken	  into	  account	  before	  the	  result	  of	  pairing	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“Biological	  Indeterminacy”	  
•  Bateson	  became	  famous	  as	  the	  outspoken	  
Mendelian	  antagonist	  of	  Walter	  Raphael	  Weldon,	  
his	  former	  teacher,	  and	  Karl	  Pearson	  who	  led	  the	  
biometric	  school	  of	  thinking.	  This	  concerned	  the	  
debate	  over	  salta=onism	  versus	  gradualism	  
(Darwin	  had	  been	  a	  gradualist,	  but	  Bateson	  was	  a	  
salta=onist).	  Later,	  Ronald	  Fisher	  and	  
J.B.S.	  Haldane	  showed	  that	  discrete	  muta=ons	  
were	  compa=ble	  with	  gradual	  evolu=on:	  see	  the	  
modern	  evolu=onary	  synthesis.	  
Biological	  Indeterminacy.	  Greenspan	  RJ.	  Sci	  Eng	  
Ethics.	  2012	  Jul	  3	  
	  

Penetrance	  and	  Expressivity	  
•  We	  do	  not	  really	  know	  the	  penetrance	  or	  
expressivity	  of	  	  pre]y	  much	  ALL	  muta=ons	  in	  
humans,	  as	  we	  have	  not	  systema=cally	  
sequenced	  or	  karyotyped	  any	  gene=c	  altera=on	  
in	  MILLIONS	  of	  well-­‐phenotyped	  people.	  
•  Do	  single	  muta=ons	  drive	  outcome	  
predominately,	  or	  are	  the	  results	  modiﬁed	  
substan=ally	  by	  other	  muta=ons	  and/or	  
environment?	  	  Is	  there	  really	  such	  a	  thing	  as	  
gene=c	  determinism	  for	  MANY	  muta=ons?	  
Some	  Deﬁni=ons	  …	  
•  The	  words	  “penetrance”	  and	  “expressivity”,	  deﬁned	  
classically	  as:	  
•  Penetrance:	  whether	  someone	  has	  ANY	  symptoms	  of	  a	  
disease,	  i.e.	  all	  or	  none,	  0%	  or	  100%.	  Nothing	  in	  between.	  
•  Expressivity:	  how	  much	  disease	  (or	  how	  many	  symptoms)	  
someone	  with	  100%	  penetrance	  has.	  
•  This	  has	  led	  to	  endless	  confusion!	  	  
•  Some	  just	  use	  the	  word	  “penetrance”	  to	  mean	  the	  
expressivity	  of	  disease,	  i.e.	  incomplete	  penetrance,	  and	  
maybe	  we	  should	  combine	  the	  two	  terms	  into	  ONE	  word	  
with	  the	  full	  expression	  from	  0-­‐100%	  of	  phenotypic	  
spectrum.	  
Deﬁni$ons.	  It	  is	  unknown	  what	  
por=on	  of	  au=sm	  will	  be	  oligogenic	  vs.	  
polygenic	  
•  Oligogenic	  –	  mul=ple	  muta=ons	  together	  
contribu=ng	  to	  aggregate	  disease,	  BUT	  with	  only	  
1	  muta=on	  of	  ~	  >10%	  penetrance	  (or	  “eﬀect	  size)	  
in	  EACH	  person.	  
•  Polygenic	  –	  Dozens	  to	  hundreds	  of	  muta=ons	  in	  
diﬀerent	  genes	  in	  the	  SAME	  person,	  together	  
contribu=ng	  to	  the	  disease	  in	  the	  SAME	  person,	  
hence	  addi$ve	  and/or	  epista$c	  contribu=on	  with	  
~0.01-­‐1%	  penetrance	  for	  each	  muta=on.	  
Example	  of	  Polygenic	  Model	  
Visscher	  et	  al.	  2011	  

Discovering	  a	  new	  syndrome	  and	  its	  
gene=c	  basis.	  
prominence	  of	  eyes,	  down-­‐sloping	  palpebral	  ﬁssures,	  thickened	  
eyelids,	  large	  ears,	  beaking	  of	  nose,	  ﬂared	  nares,	  hypoplas=c	  nasal	  
alae,	  short	  columella,	  protruding	  upper	  lip,	  micro-­‐retrognathia	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This	  is	  the	  family	  in	  Utah	  in	  December	  2009.	  
I	  met	  the	  en=re	  family	  on	  March	  29,	  2010	  
Photo	  of	  mother	  
with	  son	  in	  late	  1970’s	  
First	  boy.	  Called	  “a	  li]le	  old	  man”	  by	  
the	  family.	  Died	  around	  ~1	  year	  of	  
age,	  from	  cardiac	  arrhythmias.	  
This	  is	  the	  ﬁrst	  boy	  in	  the	  late	  1970’s.	  
Uncle	  #1	   Uncle	  #2	   cousin	   Proband-­‐	  Su]er	  
These	  are	  the	  Aﬀected	  Boys	  of	  Family	  1	  in	  2009.	  	  
Aﬀected	  males	  had	  the	  consistent	  presenta=on	  of	  an	  aged	  appearance,	  a	  dis=nct	  
and	  recognizable	  combina=on	  of	  craniofacial	  anomalies,	  post-­‐natal	  growth	  failure,	  
hypotonia,	  global	  developmental	  delays,	  cryptorchidism,	  arrhythmia,	  and	  
eventual	  death	  from	  cardiac	  failure.	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Experimental Design for Sequencing is Critical. 
 We	  performed	  X-­‐chromosome	  exon	  capture	  
with	  Agilent,	  followed	  by	  Next	  Gen	  
Sequencing	  with	  Illumina.	  
 We	  analyzed	  the	  data	  with	  ANNOVAR	  and	  
VAAST	  (Variant	  Annota$on,	  Analysis	  and	  
Search	  Tool).	  New	  computa$onal	  tools	  for	  
iden$fying	  disease-­‐causing	  muta$ons	  by	  
individual	  genome	  sequencing.	  	  
	  
Yandell,	  M.	  et	  al.	  2011.	  “A	  probabilis=c	  disease-­‐gene	  ﬁnder	  for	  personal	  
genomes.”	  Genome	  Res.	  21	  (2011).	  doi:10.1101/gr.123158.111.	  	  	  
	  
Wang,	  K.,	  Li,	  M.,	  and	  Hakonarson,	  H.	  (2010).	  ANNOVAR:	  func=onal	  annota=on	  





The	  Exon	  Capture	  and	  Coverage	  was	  
high	  depth.	  
!
Table 2. Coverage Statistics in Family 1. Based on GNUMAP 



































* On chromosome X, there are 8,222 unique RefSeq exons. Of these exons, 736 were excluded from the SureSelect X-Chromosome Capture 
Kit because they were designated as pseudoautosomal or repetitive sequences (UCSC genome browser). 
Found	  one	  muta$on	  that	  seems	  to	  contribute	  
The	  muta=on	  in	  NAA10	  is	  necessary,	  but	  we	  do	  not	  know	  if	  it	  is	  suﬃcient	  to	  cause	  this	  
phenotype	  in	  ANY	  gene=c	  background.	  It	  simply	  “contributes	  to”	  the	  phenotype.	  
The	  muta$on	  disrupts	  the	  N-­‐terminal	  
acetyla$on	  machinery	  (NatA)	  in	  
human	  cells.	  	  
Slide	  courtesy	  of	  Thomas	  Arnesen	  
NAT	  ac$vity	  of	  recombinant	  hNaa10p	  
WT	  or	  p.Ser37Pro	  towards	  synthe$c	  
N-­‐terminal	  pep$des	  	  
	  hNaa10p-­‐S37P	  is	  func$onally	  
impaired	  in	  vivo	  using	  a	  yeast	  model.	  
	  
Unpublished	  data	  from	  Thomas	  Arnesen,	  do	  not	  further	  distribute.	  
By	  November	  2010,	  we	  had	  good	  
func=onal	  data	  in	  vitro	  (bacterially	  
expressed	  proteins)	  and	  in	  vivo	  (yeast,	  
unpublished),	  leading	  me	  to	  believe	  
we	  had	  iden=ﬁed	  the	  causa=ve	  
muta=on.	  
	  
A	  new	  mother	  in	  the	  family	  informs	  me	  
she	  is	  4	  months	  pregnant,	  with	  a	  boy!	  
The	  now	  pregnant	  mother-­‐to-­‐be	  is	  circled	  in	  red.	  
Our	  Sanger	  Sequencing	  had	  shown	  her	  to	  be	  a	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Family	  now,	  with	  ﬁve	  muta$on-­‐posi$ve	  boys	  dying	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systems and infrastructure to facilitate health information exchange so that 
data can be easily aggregated and studied.213 Integrating whole genome 
sequence data into health records within the learning health system model 
can provide researchers with more data to perform genome-wide analyses, 
which in turn can advance clinical care. Several Institute of Medicine (IOM) 
working groups have supported these goals, outlining the desirability of 
establishing a universal health information technology system and learning 
environment that engages health care providers and patients. The IOM 
reports recommend that such a system include both genomic and clinical 
information, increased interoperability of medical records systems, and 
reduced barriers to data sharing.214 The President’s Council of Advisors 
on Science and Technology identified the lack of sharing electronic health 
records—with patients, with a patient’s health care providers at other 
organizations, with public health agencies, and with researchers—as a barrier 
to improved health care.215
Recommendation 4.1
Funders of whole genome sequencing research, relevant clinical entities, 
and the commercial sector should facilitate explicit exchange of information 
between genomic researchers and clinicians, while maintaining robust data 
protection safeguards, so that whole genome sequence and health data can be 
shared to advance genomic medicine.
Performing all whole genome sequencing in CLIA-approved laboratories 
would remove one of the barriers to data sharing. It would help ensure that 
whole genome sequencing generates high-quality data that clinicians and 
researchers can use to draw clinically relevant conclusions. It would also 
ensure that individuals who obtain their whole genome sequence data could 
share them more confidently in patient-driven research initiatives, producing 
more meaningful data. !at said, current sequencing technologies and those 
in development are diverse and evolving, and standardization is a substantial 
challenge. Ongoing efforts, such as those by the Standardization of Clinical 
Testing working group are critical to achieving standards for ensuring the 
reliability of whole genome sequencing results, and facilitating the exchange 






II-­‐1	   II-­‐6	   III-­‐7	  III-­‐4	   III-­‐6	  
Ancestry	  MaSers!	  -­‐	  Ogden	  Syndrome	  	  
The	  muta=on	  in	  NAA10	  is	  necessary,	  but	  we	  do	  not	  know	  if	  it	  is	  suﬃcient	  to	  cause	  this	  
phenotype	  in	  ANY	  gene=c	  background.	  It	  simply	  “contributes	  to”	  the	  phenotype.	  
 Simulated	  structure	  of	  S37P	  mutant	  	  
?	  
Big	  Ques=on:	  









































































































Could	  be	  X-­‐linked,	  	  Autosomal	  Recessive,	  mul=-­‐allelic	  or	  polygenic	  threshold	  eﬀect?	  
New	  Syndrome	  with	  Dysmorphology,	  Mental	  	  
1.5	  years	  old	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3.5	  years	  old 	   	   	   	  7	  years	  old 	   	  	  
3	  years	  old	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	  years	  old 	   	   	   	  	  	  9	  years	  old 	  	  
Workup	  Ongoing	  for	  past	  10	  years	  
•  Numerous	  gene=c	  tests	  nega=ve,	  including	  nega=ve	  for	  
Fragile	  X	  and	  many	  candidate	  genes.	  
•  No	  obvious	  pathogenic	  CNVs	  –	  several	  microarrays	  
without	  any	  deﬁni=ve	  result.	  
•  Sequenced	  whole	  genomes	  of	  Mother,	  Father	  and	  Two	  
Boys,	  using	  Complete	  Genomics,	  obtained	  data	  in	  June	  
of	  this	  year,	  i.e.	  version	  2.0	  CG	  pipeline.	  
Jason	  O’Rawe	  
Complete	  Genomics	  chemistry	  -­‐	  combinatorial	  
probe	  anchor	  liga=on	  (cPAL)	  
•  No	  obvious	  pathogenic	  CNVs	  in	  both	  brothers.	  
•  One	  puta=ve	  set	  of	  interes=ng	  compound	  
heterozygote	  muta=ons	  in	  both	  brothers,	  but	  
valida=ng	  now	  with	  Sanger	  sequencing.	  The	  
mechanism	  of	  this	  is	  uncertain?	  
•  No	  other	  obvious	  disease-­‐contributory	  
autosomal	  recessive	  SNVs	  or	  indels	  in	  protein-­‐
coding	  regions	  in	  both	  brothers.	  











Chromosome	   Posi=on	   Reference	   Coding?	   SIFT	  Score	   Score	  <=	  0.05	   Ref/Alt	  Alleles	  
X	   47307978	   G	   YES	   0.649999976	   0	   G/T	  
X	   63444792	   C	   YES	   0	   1	   C/A	  
X	   70621541	   T	   YES	   0.009999999776	   1	   T/C	  
Variant	   Reference	   Alternate	   Classiﬁca=on	   Gene	  1	   Transcript	  1	   Exon	  1	   HGVS	  Coding	  1	   HGVS	  Protein	  1	  
X:47307978-­‐SNV	   G	   T	   Nonsyn	  SNV	   ZNF41	   NM_007130	   5	  c.1191C>A	   p.Asp397Glu	  
X:63444792-­‐SNV	   C	   A	   Nonsyn	  SNV	   ASB12	   NM_130388	   2	  c.739G>T	   p.Gly247Cys	  
X:70621541-­‐SNV	   T	   C	   Nonsyn	  SNV	   TAF1	   NM_004606	   25	  c.4010T>C	   p.Ile1337Thr	  
RANK	   Gene	   p-­‐value	   p-­‐value-­‐ci	   Score	   Variants	  
1	   ASB12	   1.56E-­‐11	   1.55557809307134e-­‐11,0.000290464582480396	   38.63056297	   chrX:63444792;38.63;C-­‐>A;G-­‐>C;0,3	  
2	   TAF1	   1.56E-­‐11	   1.55557809307134e-­‐11,0.000290464582480396	   34.51696816	   chrX:70621541;34.52;T-­‐>C;I-­‐>T;0,3	  
3	   ZNF41	   1.56E-­‐11	   1.55557809307134e-­‐11,0.000290464582480396	   32.83011803	   chrX:47307978;32.83;G-­‐>T;D-­‐>E;0,3	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Mutations in the ZNF41 Gene Are Associated with Cognitive Deficits:
Identification of a New Candidate for X-Linked Mental Retardation
Sarah A. Shoichet,1 Kirsten Hoffmann,1 Corinna Menzel,1 Udo Trautmann,2 Bettina Moser,1
Maria Hoeltzenbein,1 Bernard Echenne,3 Michael Partington,4 Hans van Bokhoven,5
Claude Moraine,6 Jean-Pierre Fryns,7 Jamel Chelly,8 Hans-Dieter Rott,2 Hans-Hilger Ropers,1
and Vera M. Kalscheuer1
1Max-Planck-Institute for Molecular Genetics, Berlin; 2Institute of Human Genetics, University of Erlangen-Nuremberg, Erlangen-Nuremberg;
3Centre Hospitalier Universitaire de Montpellier, Hoˆpital Saint-Eloi, Montpellier, France, 4Hunter Genetics and University of Newcastle,
Waratah, Australia; 5Department of Human Genetics, University Medical Centre, Nijmegen, The Netherlands; 6Services
de Ge´ne´tique–INSERM U316, CHU Bretonneau, Tours, France; 7Center for Human Genetics, Clinical Genetics Unit, Leuven, Belgium;
and 8Institut Cochin de Ge´ne´tique Moleculaire, Centre National de la Recherche Scientifique/INSERM, CHU Cochin, Paris
Nonsyndromic X-linkedmental retardation (MRX) is defined by anX-linked inheritance pattern of low IQ, problems
with adaptive behavior, and the absence of additional specific clinical features. The 13 MRX genes identified
to date account for less than one-fifth of all MRX, suggesting that numerous gene defects cause the disorder in
other families. In a female patient with severe nonsyndromic mental retardation and a de novo balanced translocation
t(X;7)(p11.3;q11.21), we have cloned the DNA fragment that contains the X-chromosomal and the autosomal break-
point. In silico sequence analysis provided no indication of a causative role for the chromosome 7 breakpoint in
mental retardation (MR), whereas, on the X chromosome, a zinc-finger gene, ZNF41, was found to be disrupted.
Expression studies indicated that ZNF41 transcripts are absent in the patient cell line, suggesting that the mental
disorder in this patient results from loss of functional ZNF41. Moreover, screening of a panel of patients with
MRX led to the identification of two other ZNF41 mutations that were not found in healthy control individuals.
A proline-to-leucine amino acid exchange is present in affected members of one family with MRX. A second family
carries an intronic splice-site mutation that results in loss of specific ZNF41 splice variants. Wild-type ZNF41
contains a highly conserved transcriptional repressor domain that is linked to mechanisms of chromatin remodeling,
a process that is defective in various other forms of MR. Our results suggest that ZNF41 is critical for cognitive
development; further studies aim to elucidate the specific mechanisms by which ZNF41 alterations lead to MR.
Introduction
Developmental delay, also referred to as “mental retar-
dation” (MR), affects an estimated 2%–3% of the popu-
lation (Chelly and Mandel 2001). Although the etiology
of MR is complex and poorly understood, recent inves-
tigations have highlighted the importance of genetic fac-
tors in cognitive development. In particular, studies of the
X chromosome have confirmed that there are numerous
specific monogenic forms of MR. Of significant historical
importance is the recognition of fragile X syndrome
(FRAXA) and the identification of the FMR1 gene (MIM
309550). FRAXA is caused by a CGG repeat expansion
in the FMR1 5′ UTR, which is then abnormally methyl-
ated. Accounting for 2%–2.5% of the established X-
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linked forms of MR (XLMR), this syndrome is the most
common cause of XLMR known at present (for review,
see Jin and Warren [2003]). XLMR is now divided into
two subgroups: syndromic XLMR (MRXS), which in-
cludes FRAXA and other MR-associated disorders that
can be defined by a set of specific clinical features, and
MRX, which includes all X-linked forms ofMR forwhich
the only consistent clinical feature is MR. To date, 30
genes responsible for MRXS and 13 genes responsible for
MRX have been cloned (Frints et al. 2002; Hahn et al.
2002; Vervoort et al. 2002). The recent discovery that
mutations in ARX (MIM 300382)—the human homo-
logue of the Drosophila gene Aristaless—are responsible
for syndromic MRX with infantile spasms, Partington
syndrome (MIM 309510), and MRX (Bienvenu et al.
2002; Stromme et al. 2002) clearly illustrates that mu-
tations in a single disease gene may result in a relatively
broad spectrum of clinical features. This phenomenon has
been observed for an increasing number of genes impli-
cated in bothMRXS andMRX, includingMECP2 (MIM
300005) (Amir et al. 1999; Couvert et al. 2001; Yntema
et al. 2002), AGTR2 (MIM 300034) (Vervoort et al.
Am. J. Hum. Gen t. 73:1341–1354, 2003
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linked forms of MR (XLMR), this syndrome is the most
common cause of XLMR known at present (for review,
see Jin and Warren [2003]). XLMR is now divided into
two subgroups: syndromic XLMR (MRXS), which in-
cludes FRAXA and other MR-associated disorders that
can be defined by a set of specific clinical features, and
MRX, which includes all X-linked forms ofMR forwhich
the only consistent clinical feature is MR. To date, 30
genes responsible for MRXS and 13 genes responsible for
MRX have been cloned (Frints et al. 2002; Hahn et al.
2002; Vervoort et al. 2002). The recent discovery that
mutations in ARX (MIM 300382)—the human homo-
logue of the Drosophila gene Aristaless—are responsible
for syndromic MRX with infantile spasms, Partington
syndrome (MIM 309510), and MRX (Bienvenu et al.
2002; Stromme et al. 2002) clearly illustrates that mu-
tations in a single disease gene may result in a relatively
broad spectrum of clinical features. This phenomenon has
been observed for an increasing number of genes impli-
cated in bothMRXS andMRX, includingMECP2 (MIM
300005) (Amir et al. 1999; Couvert et al. 2001; Yntema
et al. 2002), AGTR2 (MIM 300034) (Vervoort et al.
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Figure 6 Northern blot hybridization of ZNF41, by use of a probe corresponding to nucleotides 621–1099 of ZNF41 transcript variant
1. A, Adult tissues (left to right): heart, brain, placenta, lung, liver, skeletal muscle, kidney, and pancreas. B, Fetal tissues (left to right): brain,
lung, liver, and kidney.C,Adult brain structures (left to right): amygdala, caudate nucleus, corpus callosum, hippocampus, whole brain, substantia
nigra, and thalamus. Black arrowheads highlight the presence of a novel 6-kb transcript. Actin (A and C) or GAPDH (B) served as controls
for RNA loading.
sible for sequence-specific DNA binding. ZNF41, absent
in our patient, is a member of the subfamily of Krueppel-
type zinc-finger proteins harboring a highly conservedN-
terminal domain known as the Krueppel-associated box
(KRAB). Although the specific functions of ZNF41 are
not fully understood, various related genes play an es-
tablished and important role in human development and
disease (Ladomery and Dellaire 2002). In another female
patient with severe MRX and a balanced tra slocation,
the disorder probably esulted from t disruption of a
related X-chromosomal zinc-fing r gene (Lossi et al.
2002). The X-chromosome breakpoint was located just
upstream of the Krueppel-like factor 8 (KLF8 [MIM
300286]), also k own as the “ZNF741 gene,” and it was
confirmed that KLF8 transcripts were absent in the pa-
tient cell line. The Wilms tumor suppressor gene WT1
(MIM 194070), hich arbors four Krueppel-type zinc
fingers, has been implicated in several urogenital devel-
opmental disorders, including WAGR syndrome (MIM
194072), which is associated with MR (Call et al. 1990;
Rose et al. 1990; Gessler et al. 1992). Of particular rel-
evance, however, are the biochemical studies that high-
light the links betwee th highly conserved KRAB/ZFP
s bfamily of zinc-fing r proteins and chromatin remod-
eling. Many disorders, several of which are associated
with MR, have been linked to defects in processes that
govern chromatin structural modification (Hendrich and
Bickmore 2001), suggesting that chromatin structural
regula ionmay play a specific and important role in path-
ways critical for mental function.
Repression of transcription by a KRAB/ZFP requires
binding of the corepressor KAP-1 (also known as
“TIF1b” and “KRIP-1” [MIM 601742]) (Friedman et
al. 1996; Kim et al. 1996; Moosmann et al. 1996; Peng
et al. 2000a, 2000b). KAP-1 is a molecular scaffold that
coordinates gene-specific ilencing by recruiting both
heterochromatin-associated proteins (Ryan et al. 1999)
and by interacting with the novel histone H3 Lys9–
specific methyltransferase SETDB1 (MIM 604396)
(Schultz et al. 2002). It is interesting that, within the
primary sequence of SETDB1, Schultz et al. (2002) iden-
tified a methyl CpG–binding domain that is related to
the domain found in the methyl CpG binding protein
MeCP2, which is mutated both in patients with Rett
syndrome (MIM 312750) (Amir et al. 1999) and in
pati nts with MRX (Couvert et al. 2001; Yntema et al.
2002). Like ZNF41, MECP2 is ubiquitously expressed;
yet loss of functional protein results in a neurological
phenotype. Although the mechanism by whichMECP2
mutations cause MR is not clear, it is well established
that MeCP2 binds to methylated CpGs and represses
transcription (for review, see Ballestar and Wolffe
[2001]), and it has recently been shown that MeCP2
associates with an unidentified methyltransferase that
sp cifically methylates Lys9 of histone H3 (Fuks et al.
2003), as does the KAP-1/KRAB/ZFP binding partner
SETDB1.
Further characterization of the KRAB/KAP-1 repres-
sor module has indicated that, in addition to the KRAB
domain, a bipartite domain of the plant homeodomain
(PHD) finger and a bromodomain, located within the C-
terminal portion of KAP-1, are also required for effective
gene silencing (Schultz et al. 2002). It is interesting that
the point mutations in that study were modeled after
naturally occurring mutations in the PHD finger of the
human ATRX gene, which has been implicated in both
X-linked a-thalassemia/MR syndrome (MIM 301040)
(Gibbons et al. 1995) and Juberg-Marsidi syndrome
(MIM 309590), which is also associated with MR (Vil-
lard et al. 1996a). In light of the fact that the PHD
•  KRAB	  (Kruppel-­‐associated	  box)	  domain	  -­‐A	  box.	  
•  The	  KRAB	  domain	  is	  a	  transcrip=on	  repression	  module,	  found	  
in	  a	  subgroup	  of	  the	  zinc	  ﬁnger	  proteins	  (ZFPs)	  of	  the	  C2H2	  
family,	  KRAB-­‐ZFPs.	  KRAB-­‐ZFPs	  comprise	  the	  largest	  group	  of	  
transcrip=onal	  regulators	  in	  mammals,	  and	  are	  only	  found	  in	  
tetrapods.	  	  
•  The	  KRAB	  domain	  is	  a	  protein-­‐protein	  interac=on	  module	  
which	  represses	  transcrip=on	  through	  recrui=ng	  corepressors.	  
The	  KAP1/	  KRAB-­‐AFP	  complex	  in	  turn	  recruits	  the	  
heterochroma=n	  protein	  1	  (HP1)	  family,	  and	  other	  chroma=n	  
modula=ng	  proteins,	  leading	  to	  transcrip=onal	  repression	  
through	  heterochroma=n	  forma=on.	  
1348 Am. J. Hum. Genet. 73:1341–1354, 2003
Figure 4 A, Pedigree of family P13, with sequence corresponding to the prolinerleucinemutation (left to right): unrelated control individual,
mother (II:1), index patient (III:2), and brother of the index patient (III:1). For the potentially affected female cousin (individual III-4) (indicated
with an asterisk [*]), no clinical data are available. Affected nucleotides are indicated with black arrows. B, Pedigree for family P42, with
sequence chromatograms indicating the splice-site mutation in affected individuals (left to right): father (I:1), mother (I:2), index patient (II:1),
and mildly affected sister (II:2). Uppercase letters indicate coding sequence; affected nucleotides are indicated with black arrows.
a diagnosis of mild MR. He was born at term (by Ce-
sarean section), with a birth weight of 3,000 g (10th–25th
percentile) and a length of 51 cm (50th percentile). He
walked at age 12–13 mo and reached early milestones
within the normal time frame; however, he exhibited a
severe language delay. He first made two-word associa-
tions at age 3 years and was first speaking in simple
phrases at age 4 years 6 mo. At age 8 years, he was 135
cm tall (90th percentile) and had a head circumference
of 53 cm (75th percentile). He had no additional dys-
morphic or neurological symptoms, and results of
screening for fragile X were negative. At age 10 years 3
“The	  P111L	  change	  also	  found	  in	  two	  
"male	  controls"	  (EVS	  server,	  ESP6500).	  
	  
More	  recently,	  we	  have	  iden=ﬁed	  this	  
change	  in	  another	  family	  with	  XLID.	  Co-­‐
segrega=on	  analysis	  in	  this	  family	  is	  in	  
progress.	  	  
	  
Furthermore,	  there	  are	  two	  rare,	  likely	  
heterozygous	  ZNF41	  frameshi	  
muta=ons	  and	  one	  heterozygous	  stop-­‐















































































Sanger	  valida$on:	  	  ASB12	  and	  ZNF41	  muta$ons	  
The	  muta=on	  in	  ZNF41	  may	  NOT	  be	  necessary,	  and	  it	  is	  certainly	  
NOT	  suﬃcient	  to	  cause	  the	  phenotype.	  
Proving	  Whether	  this	  Muta$on	  is	  Necessary	  and	  Suﬃcient	  
to	  result	  in	  the	  phenotype.	  
	  
•  Will	  need	  to	  ﬁnd	  a	  second,	  unrelated	  family	  with	  same	  
exact	  muta=on	  and	  similar	  phenotype.	  
	  
•  Can	  also	  perform	  in	  vitro/in	  vivo	  studies	  and	  structural	  
modeling,	  and	  make	  knock-­‐in	  mice	  and/or	  test	  in	  
zebraﬁsh,	  etc…	  for	  biological	  func=on.	  
•  But	  what	  about	  the	  False	  Nega=ve	  Rate	  in	  Complete	  
Genomes	  data?	  What	  did	  we	  miss?	  
2-­‐3	  rounds	  of	  sequencing	  at	  BGI	  to	  aSain	  
goal	  of	  >80%	  of	  target	  region	  at	  >20	  reads	  
per	  base	  pair	  
Exome Capture Statistics K24510-84060 K24510-92157-a K24510-84615 K24510-88962 
Target region (bp) 46,401,121  46,401,121  46,401,121  46,257,379  
Raw reads 138,779,950  161,898,170  156,985,870  104,423,704  
Raw data yield (Mb) 12,490  14,571  14,129  9,398  
Reads mapped to genome 110,160,277  135,603,094  135,087,576  83,942,646  
Reads mapped to target region 68,042,793  84,379,239  80,347,146  61,207,116  
Data mapped to target region (Mb) 5,337.69  6,647.18  6,280.01  4,614.47  
Mean depth of target region 115.03 143.25 135.34 99.76 
Coverage of target region (%) 0.9948  0.9947  0.9954  0.9828  
Average read length (bp) 89.91  89.92  89.95  89.75  
Fraction of target covered >=4X 98.17  98.38  98.47  94.25  
Fraction of target covered >=10X 95.18  95.90  95.97  87.90  
Fraction of target covered >=20X 90.12  91.62  91.75  80.70  
Fraction of target covered >=30X 84.98  87.42  87.67  74.69  
Capture specificity (%) 61.52  62.12  59.25  73.16  
Fraction of unique mapped bases on or near target 65.59  65.98  63.69  85.46  
Gender test result M M M F 
Depth	  of	  Coverage	  in	  15	  exomes	  >	  20	  






















Pipelines	  Used	  on	  Same	  Set	  of	  Seq	  Data	  by	  Diﬀerent	  
Analysts,	  using	  Hg19	  Reference	  Genome	  
1)  BWA	  -­‐	  GATK	  (version	  1.5)	  with	  recommended	  parameters	  	  (GATK	  IndelRealigner,	  
base	  quality	  scores	  were	  re-­‐calibrated	  by	  GATK	  Table	  Recalibra=on	  tool.	  
Genotypes	  called	  by	  GATK	  UniﬁedGenotyper.	  For	  SNVs	  and	  indels.	  
	  
2)  BWA	  -­‐	  SamTools	  version	  0.1.18	  to	  generate	  genotype	  calls	  	  -­‐-­‐	  The	  “mpileup”	  
command	  in	  SamTools	  was	  used	  for	  iden=fy	  SNVs	  and	  indels.	  
	  
3)  SOAP-­‐Align	  –	  SOAPsnp	  for	  SNVs–	  and	  BWA-­‐SOAPindel	  (adopts	  local	  assembly	  
based	  on	  an	  extended	  de	  Bruijn	  graph)	  for	  indels.	  
	  
4)  GNUMAP-­‐SNP	  (probabilis=c	  Pair-­‐Hidden	  Markov	  which	  eﬀec=vely	  accounts	  for	  
uncertainty	  in	  the	  read	  calls	  as	  well	  as	  read	  mapping	  in	  an	  unbiased	  fashion),	  for	  
SNVs	  only.	  
	  
5)  BWA	  -­‐	  Sam	  format	  to	  Bam	  format	  -­‐	  Picard	  to	  remove	  duplicates	  –	  SNVer	  ,	  for	  SNVs	  
only	  
Known	   Novel	  
All	  
Total	  mean	  overlap,	  plus	  or	  minus	  one	  standard	  devia$on,	  observed	  between	  three	  
indel	  calling	  pipelines:	  GATK,	  SOAP-­‐indel,	  and	  SAMTools.	  	  a)	  Mean	  overlap	  when	  indel	  
posi=on	  was	  the	  only	  necessary	  agreement	  criterion.	  b)	  Mean	  overlap	  when	  indel	  
posi=on,	  base	  length	  and	  base	  composi=on	  were	  the	  necessary	  agreement	  criteria.	  	  	  
Indels-­‐	  Overlap	  by	  Base	  	  
Posi=on	  only	  
Indels-­‐	  Overlap	  by	  Base	  	  
Posi=on,	  Length	  and	  Composi=on	  
INDELS	  
•  How	  reliable	  are	  variants	  that	  are	  uniquely	  
called	  by	  individual	  pipelines?	  
•  Are	  some	  pipelines	  be]er	  at	  detec=ng	  rare,	  or	  
novel	  variants	  than	  others?	  
Cross	  valida=on	  using	  orthogonal	  
sequencing	  technology	  







What	  is	  the	  “True”	  Personal	  Genome?	  
35653	   19407	  17322	  
2666	  
18331	   2085	  
915	  
50.5%	   32.2%	   17.3%	  
48.6%	   45.9%	   5.5%	  
Known	   Novel	  
All	  












































Personal	  genome	  “K8101”	  
All	  
Higher	  Valida=on	  of	  SNVs	  with	  the	  
BWA-­‐GATK	  pipeline	  
•  Reveals	  higher	  valida=on	  rate	  of	  unique-­‐to-­‐
pipeline	  variants,	  as	  well	  as	  uniquely	  
discovered	  novel	  variants,	  for	  the	  variants	  
called	  by	  BWA-­‐GATK,	  in	  comparison	  to	  the	  
other	  4	  pipelines	  (including	  SOAP).	  
Much	  Higher	  Valida=on	  of	  the	  Concordantly	  
Called	  SNVs	  (by	  the	  CG	  data)	  
Valida=ng	  Indels	  with	  Complete	  
Genomics	  Data	  for	  the	  3	  pipelines	  
Valida$on	  with	  PCR	  amplicons	  and	  MiSeq	  150	  bp	  reads	  at	  ~5000x	  coverage	  
Valida$on	  with	  PCR	  amplicons	  and	  MiSeq	  150	  bp	  reads	  at	  ~5000x	  coverage	  
Clinical	  Validity?	  
	  
This	  is	  SO	  complex	  that	  the	  only	  solid	  
way	  forward	  is	  with	  a	  “networking	  of	  
science”	  model,	  i.e.	  online	  database	  
with	  genotype	  and	  phenotype	  





Clinical	  Validity	  with	  Worldwide	  
Human	  Gene=c	  Varia=on	  “database”?	  
Pa$entsLikeMe	  
Conclusions	  
•  Ancestry,	  i.e.	  gene=c	  background,	  ma]ers!	  
•  We	  need	  to	  sequence	  whole	  genomes	  of	  large	  
pedigrees,	  and	  then	  construct	  super-­‐family	  
structures.	  
•  Collec=vely,	  we	  need	  to	  improve	  the	  accuracy	  
of	  “whole”	  genomes.	  
•  We	  must	  share	  genotype	  and	  phenotype	  data	  
broadly,	  among	  researchers,	  the	  research	  





Figure 4. NAT activity of recombinant hNaa10p WT or p.Ser37Pro 
towards synthetic N-terminal peptides. A) and B) Purified MBP-hNaa10p 
WT or p.Ser37Pro were mixed with the indicated oligopeptide substrates (200 
µM for SESSS and 250 µM for DDDIA) and saturated levels of acetyl-CoA 
(400 µM). Aliquots were collected at indicated time points and the acetylation 
reactions were quantified using reverse phase HPLC peptide separation. 
Error bars indicate the standard deviation based on three independent 
experiments. The five first amino acids in the peptides are indicated, for 
further details see materials and methods. Time dependent acetylation 
reactions were performed to determine initial velocity conditions when 
comparing the WT and Ser37Pro NAT-activities towards different 
oligopeptides. C) Purified MBP-hNaa10p WT or p.Ser37Pro were mixed with 
the indicated oligopeptide substrates (200 µM for SESSS and AVFAD, and 
250 µM for DDDIA and EEEIA) and saturated levels of acetyl-CoA (400 µM) 
and incubated for 15 minutes (DDDIA and EEEIA) or 20 minutes (SESSS and 
AVFAD), at 37°C in acetylation buffer. The acetylation activity was determined 
as above. Error bars indicate the standard deviation based on three 
independent experiments. Black bars indicate the acetylation capacity of the 
MBP-hNaa10p wild type (WT), while white bars indicate the acetylation 
capacity of the MBP-hNaa10p mutant p.Ser37Pro. The five first amino acids 
in the peptides are indicated. 
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Extra Slides to follow this last slide. 
“To	  Cause”,	  or	  “Causa=ve”	  
•  Koch’s	  postulates	  for	  the	  21st	  century	  (from	  Wikipedia)	  
•  Koch’s	  postulates	  have	  played	  an	  important	  role	  in	  microbiology,	  yet	  they	  have	  major	  limita=ons.	  For	  example,	  Koch	  was	  
well	  aware	  that	  in	  the	  case	  of	  cholera,	  the	  causal	  agent,	  Vibrio	  cholerae,	  could	  be	  found	  in	  both	  sick	  and	  healthy	  people,	  
invalida=ng	  his	  ﬁrst	  postulate.	  Furthermore,	  viral	  diseases	  were	  not	  yet	  discovered	  when	  Koch	  formulated	  his	  postulates,	  
and	  there	  are	  many	  viruses	  that	  do	  not	  cause	  illness	  in	  all	  infected	  individuals,	  a	  requirement	  of	  the	  ﬁrst	  postulate.	  
•  More	  recently,	  modern	  nucleic	  acid-­‐based	  microbial	  detec=on	  methods	  have	  made	  Koch’s	  original	  postulates	  even	  less	  
relevant.	  These	  nucleic	  acid-­‐based	  methods	  make	  it	  possible	  to	  iden=fy	  microbes	  that	  are	  associated	  with	  a	  disease,	  but	  
in	  many	  cases	  the	  microbes	  are	  uncul=vable.	  Also,	  nucleic	  acid-­‐based	  detec=on	  methods	  are	  very	  sensi=ve,	  and	  they	  can	  
oen	  detect	  the	  very	  low	  levels	  of	  viruses	  that	  are	  found	  in	  healthy	  people	  without	  disease.	  
•  The	  use	  of	  these	  new	  methods	  has	  led	  to	  revised	  versions	  of	  Koch’s	  postulates:	  Fredricks	  and	  Relman[11]	  have	  suggested	  
the	  following	  set	  of	  Koch’s	  postulates	  for	  the	  21st	  century:	  
•  A	  nucleic	  acid	  sequence	  belonging	  to	  a	  puta=ve	  pathogen	  should	  be	  present	  in	  most	  cases	  of	  an	  infec=ous	  disease.	  
Microbial	  nucleic	  acids	  should	  be	  found	  preferen=ally	  in	  those	  organs	  or	  gross	  anatomic	  sites	  known	  to	  be	  diseased,	  and	  
not	  in	  those	  organs	  that	  lack	  pathology.	  
•  Fewer,	  or	  no,	  copies	  of	  pathogen-­‐associated	  nucleic	  acid	  sequences	  should	  occur	  in	  hosts	  or	  =ssues	  without	  disease.	  
•  With	  resolu=on	  of	  disease,	  the	  copy	  number	  of	  pathogen-­‐associated	  nucleic	  acid	  sequences	  should	  decrease	  or	  become	  
undetectable.	  With	  clinical	  relapse,	  the	  opposite	  should	  occur.	  
•  When	  sequence	  detec=on	  predates	  disease,	  or	  sequence	  copy	  number	  correlates	  with	  severity	  of	  disease	  or	  pathology,	  
the	  sequence-­‐disease	  associa=on	  is	  more	  likely	  to	  be	  a	  causal	  rela=onship.	  
•  The	  nature	  of	  the	  microorganism	  inferred	  from	  the	  available	  sequence	  should	  be	  consistent	  with	  the	  known	  biological	  
characteris=cs	  of	  that	  group	  of	  organisms.	  
•  Tissue-­‐sequence	  correlates	  should	  be	  sought	  at	  the	  cellular	  level:	  eﬀorts	  should	  be	  made	  to	  demonstrate	  speciﬁc	  in	  situ	  
hybridiza=on	  of	  microbial	  sequence	  to	  areas	  of	  =ssue	  pathology	  and	  to	  visible	  microorganisms	  or	  to	  areas	  where	  
microorganisms	  are	  presumed	  to	  be	  located.	  
•  These	  sequence-­‐based	  forms	  of	  evidence	  for	  microbial	  causa=on	  should	  be	  reproducible.	  
